LAMPERTICO, PIETRO

LAMPERTICO, PIETRO  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 439 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B 2025 Lampertico, Pietro + Article (author) -
Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy 2025 Lampertico, Pietro + Article (author) -
Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg‐IFNα‐2a as Treatment for Chronic Hepatitis Delta 2025 Lampertico, Pietro + Article (author) -
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study 2025 Lampertico PValenti L + Article (author) -
Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV 2025 Anolli, Maria PaolaFacchetti, FlorianaLampertico, Pietro + Article (author) -
Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide 2025 Lampertico, Pietro + Article (author) -
Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA 2025 D'Ambrosio, RobertaDegasperi, ElisabettaPerbellini, RiccardoLampertico, Pietro + Article (author) -
Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48 2025 Lampertico, Pietro + Article (author) -
The impact of BCLC recommendations on survival for patients with hepatocellular carcinoma 2025 Iavarone, MassimoAlimenti, EleonoraCanova, LorenzoAntonelli, BarbaraCarrafiello, GianpaoloLampertico, Pietro + Article (author) -
High Rate of Antibody Response to Multiple Doses of the COVID-19 Vaccine in Liver Transplant Recipients: Analysis of Predictive Factors 2025 Nunzio ZignaniAndrea CostantinoClara DibenedettoRiccardo PerbelliniSara Uceda RenteriaPietro Lampertico + Article (author) -
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of Cholestasis 2025 Lampertico, PietroCerini, FedericaDegasperi, Elisabetta + Article (author) -
Reply to: Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies 2024 Lampertico, Pietro + Article (author) -
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection 2024 Degasperi, ElisabettaLampertico, Pietro + Article (author) -
Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations 2024 Anolli, Maria PaolaUceda Renteria, Sara ColoniaLampertico, Pietro + Article (author) -
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta 2024 Degasperi, ElisabettaTestoni, BarbaraRenteria, Sara UcedaAnolli, Maria PaolaFacchetti, FlorianaPerbellini, RiccardoCallegaro, AnnapaolaLampertico, Pietro + Article (author) -
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis 2024 La Mura, VincenzoLampertico, PietroPeyvandi, Flora + Article (author) -
Antiviral therapy for chronic hepatitis delta: new insights from clinical trials and real-life studies 2024 Lampertico, PietroAnolli, Maria Paola + Article (author) -
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B 2024 Lampertico, Pietro + Article (author) -
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis 2024 D'Ambrosio, RobertaTosetti, GiuliaBorghi, MartaLampertico, Pietro + Article (author) -
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories 2024 Lampertico P. + Article (author) -